CTS-21166

N/A

Report date: 2022/11/25 17:01:19

NME

Base Information

Drug NameCTS-21166

Drug Alias NameATG-Z1ASP-1702CTS-21166ZPQ-21166

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionBeta-secretase inhibitors

TargetsBeta-secretase

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesComentis Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesComentis Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A

Related LinksN/A